16 companies

D&D Pharmatech

Market Cap: ₩3.2t

Engages in the research and development and manufacturing of pharmaceuticals in South Korea.

New

A347850

₩74,000.00

7D

7.9%

1Y

511.6%

Hanmi Pharm

Market Cap: ₩6.3t

A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.

A128940

₩500,000.00

7D

-1.4%

1Y

105.8%

Peptron

Market Cap: ₩6.2t

Engages in the development of peptide-based medicines.

A087010

₩267,500.00

7D

-2.9%

1Y

62.4%

ALTEOGEN

Market Cap: ₩19.3t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩361,500.00

7D

-1.1%

1Y

-3.5%

SK Biopharmaceuticals

Market Cap: ₩7.7t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

A326030

₩98,500.00

7D

4.7%

1Y

-3.5%

Caregen

Market Cap: ₩4.2t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

A214370

₩85,600.00

7D

-20.4%

1Y

219.4%

Samsung BiologicsLtd

Market Cap: ₩72.7t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

A207940

₩1,571,000.00

7D

1.1%

1Y

-2.2%

OliX Pharmaceuticals

Market Cap: ₩3.3t

A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.

A226950

₩164,800.00

7D

0.5%

1Y

236.0%

PharmaResearch

Market Cap: ₩3.1t

Operates as a biopharmaceutical company primarily in South Korea.

A214450

₩302,000.00

7D

4.0%

1Y

-17.5%

ABL Bio

Market Cap: ₩8.8t

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.

A298380

₩157,700.00

7D

0.6%

1Y

180.6%

ST PharmLtd

Market Cap: ₩3.0t

Provides manufacturing services for active pharmaceutical ingredient and intermediate.

New

A237690

₩143,300.00

7D

3.8%

1Y

88.3%

Celltrion

Market Cap: ₩43.7t

A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.

A068270

₩199,700.00

7D

2.3%

1Y

28.9%

Aimed Bio

Market Cap: ₩3.1t

Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.

A0009K0

₩47,550.00

7D

-1.6%

1Y

n/a

LigaChem Biosciences

Market Cap: ₩6.9t

A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.

A141080

₩188,200.00

7D

7.5%

1Y

74.4%

Voronoi

Market Cap: ₩5.2t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.

A310210

₩287,000.00

7D

2.9%

1Y

147.4%

Yuhan

Market Cap: ₩6.9t

Operates as a pharmaceutical company in South Korea and internationally.

A000100

₩92,900.00

7D

0.1%

1Y

-15.3%